Vaxcyte, Inc. (PCVX)
Vaxcyte Market Cap : 8.737B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 8.737B |
| November 17, 2026 | 8.868B |
| November 16, 2026 | 9.198B |
| November 13, 2026 | 9.461B |
| November 12, 2026 | 9.658B |
| November 11, 2026 | 10.24B |
| November 10, 2026 | 9.907B |
| November 09, 2026 | 10.08B |
| November 06, 2026 | 9.539B |
| November 05, 2026 | 9.245B |
| November 04, 2026 | 9.806B |
| November 03, 2026 | 9.079B |
| November 02, 2026 | 9.051B |
| October 30, 2026 | 8.981B |
| October 29, 2026 | 9.065B |
| October 28, 2026 | 8.899B |
| October 27, 2026 | 8.784B |
| October 26, 2026 | 8.683B |
| October 23, 2026 | 8.749B |
| October 22, 2026 | 9.100B |
| October 21, 2026 | 9.155B |
| October 20, 2026 | 9.589B |
| October 19, 2026 | 9.220B |
| October 16, 2026 | 9.211B |
| October 15, 2026 | 9.450B |
| Date | Value |
|---|---|
| October 14, 2026 | 9.780B |
| October 13, 2026 | 9.672B |
| October 12, 2026 | 10.23B |
| October 09, 2026 | 10.33B |
| October 08, 2026 | 9.413B |
| October 07, 2026 | 9.695B |
| October 06, 2026 | 9.657B |
| October 05, 2026 | 10.69B |
| October 02, 2026 | 8.178B |
| October 01, 2026 | 8.115B |
| September 30, 2026 | 8.238B |
| September 29, 2026 | 8.208B |
| September 28, 2026 | 8.437B |
| September 25, 2026 | 8.138B |
| September 24, 2026 | 8.238B |
| September 23, 2026 | 8.180B |
| September 22, 2026 | 8.545B |
| September 21, 2026 | 8.531B |
| September 18, 2026 | 8.416B |
| September 17, 2026 | 8.741B |
| September 16, 2026 | 8.509B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.621B |
| September 11, 2026 | 8.610B |
| September 10, 2026 | 8.528B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Moderna, Inc. | 79.50B |
| Vir Biotechnology, Inc. | 1.550B |
| Anavex Life Sciences Corp. | 66.69M |
| Revolution Medicines, Inc. | 34.56B |
| Foghorn Therapeutics, Inc. | 107.33M |
Market Cap Related Metrics
| PEG Ratio | -0.1099 |
| Price to Book Value | 3.510 |
| Price | 58.52 |
| Earnings Yield | -13.91% |
| PEGY Ratio | -0.1099 |